Invention Grant
- Patent Title: Compound used as Bruton's tyrosine kinase inhibitor and preparation method and application thereof
-
Application No.: US16468658Application Date: 2017-02-20
-
Publication No.: US10793576B2Publication Date: 2020-10-06
- Inventor: Yingfu Li , Haoxi Huang , Guanfeng Liu , Tonghui Chen , Junfeng Ren , Zhonghai Su
- Applicant: Chengdu Brilliant Pharmaceutical Co., LTD. , Chengdu Highbred Pharmaceutical Co., LTD.
- Applicant Address: CN Chengdu, Sichuan CN Chengdu, Sichuan
- Assignee: CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.,CHENGDU HIGHBRED PHARMACEUTICAL CO., LTD.
- Current Assignee: CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.,CHENGDU HIGHBRED PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Chengdu, Sichuan CN Chengdu, Sichuan
- Agency: Sheppard Mullin Richter & Hampton LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1124289a
- International Application: PCT/CN2017/074108 WO 20170220
- International Announcement: WO2018/133151 WO 20180726
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P35/00 ; C07D519/00
Abstract:
The present invention provides a compound having a structure shown in formula (I) or an isomer, pharmaceutically acceptable solvate, or salt thereof. The compound is used as a Bruton's tyrosine kinase inhibitor, and has a higher inhibitory activity against BTK and less adverse effects.
Public/Granted literature
- US20190315758A1 COMPOUND USED AS BRUTON'S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF Public/Granted day:2019-10-17
Information query
